- Home
- CLGN vs MGLD Comparison
CLGN vs MGLD Comparison
Compare CLGN & MGLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLGN
- MGLD
- Stock Information
- Founded
- CLGN 2004
- MGLD 1996
- Country
- CLGN Israel
- MGLD United States
- Employees
- CLGN N/A
- MGLD 116
- Industry
- CLGN Industrial Specialties
- MGLD Finance/Investors Services
- Sector
- CLGN Health Care
- MGLD Finance
- Exchange
- CLGN Nasdaq
- MGLD Nasdaq
- Market Cap
- CLGN 44.1M
- MGLD 52.9M
- IPO Year
- CLGN N/A
- MGLD N/A
- Fundamental
- Price
- CLGN $4.19
- MGLD $1.28
- Analyst Decision
- CLGN Strong Buy
- MGLD
- Analyst Count
- CLGN 2
- MGLD 0
- Target Price
- CLGN $12.50
- MGLD N/A
- AVG Volume (30 Days)
- CLGN 18.1K
- MGLD 2.6K
- Earning Date
- CLGN 11-27-2024
- MGLD 11-26-2024
- Dividend Yield
- CLGN N/A
- MGLD N/A
- EPS Growth
- CLGN N/A
- MGLD N/A
- EPS
- CLGN N/A
- MGLD N/A
- Revenue
- CLGN $689,000.00
- MGLD $32,511,000.00
- Revenue This Year
- CLGN N/A
- MGLD N/A
- Revenue Next Year
- CLGN $670.03
- MGLD N/A
- P/E Ratio
- CLGN N/A
- MGLD N/A
- Revenue Growth
- CLGN N/A
- MGLD N/A
- 52 Week Low
- CLGN $3.61
- MGLD $0.78
- 52 Week High
- CLGN $6.99
- MGLD $1.92
- Technical
- Relative Strength Index (RSI)
- CLGN 51.28
- MGLD 48.86
- Support Level
- CLGN $3.61
- MGLD $1.15
- Resistance Level
- CLGN $4.39
- MGLD $1.47
- Average True Range (ATR)
- CLGN 0.23
- MGLD 0.08
- MACD
- CLGN 0.09
- MGLD 0.01
- Stochastic Oscillator
- CLGN 59.79
- MGLD 47.22
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
About MGLD The Marygold Companies Inc.
The Marygold Companies Inc is a holding company that intends to focus on financial services. It is currently directing its investments towards financial services and the emerging Fintech space.